Intellia Therapeutics, Inc.

NTLA · Healthcare · · USD

14.42 USD

+0.00 (2.34%)

● Updated 2026-05-12 10:52 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 75

Trend & RS 85

Momentum 82

Fundamental 22

Macro 65

Liquidity 49

Component	Score	Weight
Technical	75.0	20%
Trend & RS	84.7	30%
Momentum	81.5	15%
Fundamental	22.2	10%
Macro	65.3	20%
Liquidity	48.9	5%

Trade Setup

Entry	14.42
Stop Loss	12.20 (15.4%)
Target 1 (1:1)	16.64 (+15.4%)
Target 2 (2:1)	18.86 (+30.8%)

ATR(14)	1.11 (7.7%)
Risk per Share	2.22
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	79.0	+1.16
Momentum	81.5	+1.26
Quality	40.0	-0.40
Composite	66.8

Quality Scores

Piotroski F-Score 2 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	2.5	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

45.98%

Full Kelly

22.99%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 70/100. Estimated win rate 61%, avg win 9.2%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

54.12

RSI(14)

0.0406

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	→ FLAT (+8.6% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (13d since high)
Sector Outperformance	+18.0% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	54.12	NEUTRAL
Macd	0.0406	BEARISH
Ma Cross	13.67 / 13.19	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.91x	NORMAL

Key Levels

Level	Price
52-Week High	28.25
Bollinger Upper	16.29
SMA(200)	13.19
SMA(50)	13.67
SMA(20)	14.2
Current Price	14.42
Bollinger Lower	12.12
52-Week Low	6.83
ATR(14)	1.11

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION A Confidence

50%

Selling Climax

Acc: 2.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-05-05	Normal	0.62x	Normal bar — no special VSA pattern
2026-05-06	No Supply	0.48x	Low volume, narrow spread, firm close — no selling pressure
2026-05-07	Normal	0.51x	Normal bar — no special VSA pattern
2026-05-08	Normal	0.73x	Normal bar — no special VSA pattern
2026-05-11	Normal	0.91x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	13.65	Below Kijun
Kijun-sen (26)	14.36	Base line
Senkou A	14.01	Leading span A
Senkou B	14.29	Leading span B
Cloud	14.01 – 14.29	Bearish (Red)
Price vs Cloud	14.42	Above Cloud
Chikou Span	13.30	Bullish
Alignment Score	2/4	NEUTRAL